152 related articles for article (PubMed ID: 8054845)
1. Purification of factor VIII/von Willebrand factor from human plasma on immobilized lentil lectin.
Zhou FL; Burnouf-Radosevich M; Burnouf T
Protein Expr Purif; 1994 Apr; 5(2):138-43. PubMed ID: 8054845
[TBL] [Abstract][Full Text] [Related]
2. Chromatographic preparation of a therapeutic highly purified von Willebrand factor concentrate from human cryoprecipitate.
Burnouf-Radosevich M; Burnouf T
Vox Sang; 1992; 62(1):1-11. PubMed ID: 1580062
[TBL] [Abstract][Full Text] [Related]
3. Lectin activity of the coagulation factor VIII/von Willebrand complex.
Santizo F; Zenteno E; Pina-Canseco S; Hernandez-Cruz P; Cruz MM; Mayoral LP; Pérez-Campos E; Martínez-Cruz R
Tohoku J Exp Med; 2009 Mar; 217(3):209-15. PubMed ID: 19282656
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the von Willebrand factor/factor VIII complex produced by a novel purification process.
Ahn JW; Chang ES; Jung YJ; Kim SR; Seong BL; Ha SH
Arch Pharm Res; 2020 Jul; 43(7):714-723. PubMed ID: 32666302
[TBL] [Abstract][Full Text] [Related]
5. Progress in large-scale purification of factor VIII/von Willebrand factor concentrates using ion-exchange chromatography.
Mori F; Nardini I; Rossi P; Nardini C; Farina C
Vox Sang; 2008 Nov; 95(4):298-307. PubMed ID: 19138259
[TBL] [Abstract][Full Text] [Related]
6. Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P).
Michiels JJ; Berneman ZN; van der Planken M; Schroyens W; Budde U; van Vliet HH
Blood Coagul Fibrinolysis; 2004 Jun; 15(4):323-30. PubMed ID: 15166918
[TBL] [Abstract][Full Text] [Related]
7. Isolation of small molecular forms of Factor VIII/von Willebrand factor from plasma.
Perret BA; Furlan M; Beck EA
Haemostasis; 1984; 14(4):289-95. PubMed ID: 6437941
[TBL] [Abstract][Full Text] [Related]
8. The interaction of the factor VIII/von Willebrand factor complex (VIII/vWf), with guanidinium-derivatized matrices.
Saundry RH; Savidge GF
Bioseparation; 1991; 2(3):177-86. PubMed ID: 1368084
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetic diversity of two von Willebrand factor (VWF)/ factor VIII (FVIII) concentrates in subjects with congenital von Willebrand disease. Results from a prospective, randomised crossover study.
Kessler CM; Friedman K; Schwartz BA; Gill JC; Powell JS;
Thromb Haemost; 2011 Aug; 106(2):279-88. PubMed ID: 21725579
[TBL] [Abstract][Full Text] [Related]
10. Effect of multimerization of human and recombinant von Willebrand factor on platelet aggregation, binding to collagen and binding of coagulation factor VIII.
Fischer BE; Kramer G; Mitterer A; Grillberger L; Reiter M; Mundt W; Dorner F; Eibl J
Thromb Res; 1996 Oct; 84(1):55-66. PubMed ID: 8885147
[TBL] [Abstract][Full Text] [Related]
11. Chromatography of the VIII/vWF complex on dextran sulphate sepharose.
Harrison P; Saundry RH; Savidge GF
Thromb Res; 1988 Apr; 50(2):295-304. PubMed ID: 2455942
[TBL] [Abstract][Full Text] [Related]
12. Isolation of the factor VIII-von Willebrand factor complex directly from plasma by gel filtration.
Kaersgaard P; Barington KA
J Chromatogr B Biomed Sci Appl; 1998 Sep; 715(2):357-67. PubMed ID: 9792522
[TBL] [Abstract][Full Text] [Related]
13. In vitro studies, pharmacokinetic studies and clinical use of a high purity double virus inactivated FVIII/VWF concentrate (Immunate) in the treatment of von Willebrand disease.
Ver Elst KM; van Vliet HD; Kappers-Klunne MC; Leebeek FW
Thromb Haemost; 2004 Jul; 92(1):67-74. PubMed ID: 15213847
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
Miller CH; Kelley L; Green D
Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
[TBL] [Abstract][Full Text] [Related]
15. Purification of factor VIII and von Willebrand factor from human plasma by anion-exchange chromatography.
Josic D; Schwinn H; Stadler M; Strancar A
J Chromatogr B Biomed Appl; 1994 Dec; 662(2):181-90. PubMed ID: 7719474
[TBL] [Abstract][Full Text] [Related]
16. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
Turecek PL; Siekmann J; Schwarz HP
Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
[TBL] [Abstract][Full Text] [Related]
17. Immunopurification of human factor VIII/vWF complex from plasma.
Mejan O; Fert V; Delezay M; Delaage M; Cheballah R; Bourgois A
Thromb Haemost; 1988 Jun; 59(3):364-71. PubMed ID: 3142074
[TBL] [Abstract][Full Text] [Related]
18. The role of fibronectin in factor VIII/von Willebrand factor cryoprecipitation.
Mazurier C; Samor B; Deromeuf C; Goudemand M
Thromb Res; 1985 Mar; 37(6):651-8. PubMed ID: 3922084
[TBL] [Abstract][Full Text] [Related]
19. Clinical and biological evaluation in von Willebrand's disease of a von Willebrand factor concentrate with low factor VIII activity.
Goudemand J; Mazurier C; Marey A; Caron C; Coupez B; Mizon P; Goudemand M
Br J Haematol; 1992 Feb; 80(2):214-21. PubMed ID: 1550779
[TBL] [Abstract][Full Text] [Related]
20. Association of the factor VIII light chain with von Willebrand factor.
Lollar P; Hill-Eubanks DC; Parker CG
J Biol Chem; 1988 Jul; 263(21):10451-5. PubMed ID: 3134349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
